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Extracorporeal Cardiopulmonary Support for Cardiogenic Shock
Caused by Pheochromocytoma: A Case Report
and Literature Review
Giacomo Grasselli, M.D.,* Giuseppe Foti, M.D.,* Nicolo` Patroniti, M.D.,† Roberto Rona, M.D.,* Maria V. Perlangeli, Ph.D.,‡
Antonio Pesenti, M.D.§
PHEOCHROMOCYTOMA is classically associated with
paroxysmal hypertension but may present with various
nonspecific clinical manifestations.1 We describe here a
patient with a pheochromocytoma causing cardiogenic
shock and multiorgan failure successfully treated with
extracorporeal cardiopulmonary support.
Case Report
A 47-yr-old woman was brought to her local hospital because of
nausea, vomiting, diffuse myalgias, and deterioration in mental status.
She had been well until the night before, when, while dancing at a
party, she had reported epigastric–retrosternal discomfort, right lum-
bar pain, and vomiting with an impending sense of doom.
She had no history of hypertension, diabetes, or cardiovascular
diseases. She was a nonsmoker and nondrinker, had no allergies, and
was not taking any regular medications.
On admission, she was alert but anxious and confused. Her blood
pressure was 100/50 mm Hg, her pulse was 120/min, her respiratory
rate was 28/min, and her body temperature was 39.8°C. Physical
examination was unremarkable. An electrocardiogram showed a sinus
tachycardia with aspecific alteration of ventricular repolarization; the
corrected QT interval was 405 ms.
Echocardiography demonstrated severe biventricular dysfunction
(left ventricular ejection fraction, 30–35%) and grade 2 mitral and
tricuspidal regurgitation.
Laboratory values showed leukocytosis, hyperazotemia, hypocalce-
mia, lactic acidosis, and increased levels of transaminases, amylases,
total creatine kinase and MB fraction, troponin I, and C-reactive protein
(table 1). Arterial blood gas analysis showed lactic acidosis (partial
pressure of oxygen [PO2], 107 mm Hg; partial pressure of carbon
dioxide [PCO2], 31.9 mm Hg; pH, 7.43; bicarbonate, 22.7 mM; base
excess, 2.5; lactate, 5.7 mM).
The patient was given intravenous fluids and was immediately trans-
ferred to the intensive care unit. Further blood chemistry confirmed a
multiorgan-failure syndrome with shock, massive rhabdomyolysis (to-
tal creatine kinase, 4,519 U/l; myoglobin, 10,790 ng/ml), progressive
renal failure, hepatic cytolysis, disseminated intravascular coagulation
(platelets, 59,000/l; prothrombin time international normalized ratio,
1.95; fibrinogen, 246 mg/dl; D-dimer, 18,446 g/l; antithrombin III,
64%), and respiratory failure. The patient was intubated and mechan-
ically ventilated.
The most common toxic causes of rhabdomyolysis were excluded:
The patient was not taking any medication associated with myopathy
(lipid-lowering drugs, antiretroviral drugs, corticosteroids, cyclospor-
ine), and toxicologic tests on blood and urine were negative for
cocaine, opiates, amphetamines, ecstasy, and alcohol.
An arterial line and pulmonary artery catheter were inserted. Blood
pressure was 90/50 mm Hg; pulmonary artery pressure was 35/25
mm Hg; central venous pressure and pulmonary artery occlusion pressure
were 7 and 20 mm Hg, respectively; cardiac index was 2 l · min1 · m2;
and mixed venous blood saturation (SvO2) was 59.7%. Inotropic support
with dobutamine and norepinephrine was started.
On a presumptive diagnosis of severe septic shock, a broad spec-
trum antimicrobial therapy with meropenem and metronidazole was
started.
Hydration, forced diuresis (with loop diuretics and fenoldopam),
and urine alkalinization were instituted.
Despite initial therapy, the patient rapidly developed acute renal
failure necessitating renal replacement therapy. Because this treatment
was not available in the unit of admission, she was transferred to our
intensive care unit.
The differential diagnosis included an acute viral infection causing
myocarditis and hepatitis or an atypical presentation of a vasculitic
syndrome. Complete viral and autoimmune tests yielded negative re-
sults, as well as serial cultures of blood, urine, and respiratory secre-
tions. A computed tomography scan revealed an adrenal mass with a
radiologic aspect highly suggestive of a pheochromocytoma (fig. 1).
Continuous venovenous hemofiltration was instituted to support
renal function.
Hemodynamic conditions also deteriorated, with marked increase of
ventricular filling pressures (up to central venous pressure values of 27
mm Hg and pulmonary artery occlusion pressure values of 37 mm Hg)
and a cardiac index of 2.6 l · min1 · m2 despite maximal support with
vasoactive drugs.
Passive venous congestion due to right ventricular failure led to a
progressive worsening of liver function, with marked increases of
transaminases and bilirubin (up to 18.9 mg/dl), further impairment of
coagulation, and reduction of indocyanine green clearance (plasma
disappearance rate, 2.8%).
We decided to institute venoarterial extracorporeal bypass. A 24-
French cannula was positioned percutaneously into the right common
femoral vein, and a 12-French arterial catheter was inserted into the
right common femoral artery. Venous blood was drained from inferior
vena cava and propelled by a centrifugal pump (Jostra Rotaflow®;
Maquet Cardiopulmonary AG, Hechingen, Germany) through an artifi-
cial lung (Jostra Quadrox®; Maquet Cardiopulmonary AG) for gas
exchange before returning it into the arterial circulation. Extracorpo-
real blood flow was initially set to 5 l/min and gas flow through the
artificial lung adjusted to maintain normal pH and PCO2.
Anticoagulation was maintained with continuous infusion of unfrac-
tionated heparin, titrated to an activated clotting time of 190–210 s.
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Within few hours, the patient’s hemodynamics improved, with re-
turn of central venous pressure and pulmonary artery occlusion pres-
sure to normal values and marked increase of SvO2. Unexpectedly,
soon after withdrawal of catecholamine infusion, wide and rapid fluc-
tuations in blood pressure (from 70/40 to 190/110 mm Hg) became
evident (fig. 2). These variations were associated with very high plas-
matic levels of catecholamines and of their urinary metabolites (table
2), strongly suggesting the presence of a functioning pheochromocy-
toma. In addition, the level of the neuroendocrine tumor marker
chromogranin A was markedly increased (4,375 U/l, with normal
values 70 U/l). Because of the critical conditions of the patient, a
scintigraphy with metaiodobenzylguanidine could not be obtained.
Treatment with phentolamine by continuous intravenous infusion
was started.
After sustained improvement of hemodynamics, the extracorporeal
bypass was discontinued on day 4.
After consultation with the surgeon, we decided to perform an
angiographic study with selective embolization of the tumor; the arte-
riographic study showed a highly vascularized adrenal mass and vaso-
spasm of renal and hepatic arteries. In the first hours after emboliza-
tion, the hypertensive–hypotensive crises transiently resolved but
unfortunately reappeared approximately 24 h after the procedure.
For this reason, 2 days later, a right laparotomic adrenalectomy
was performed, with radical resection of the tumor. General anes-
thesia was maintained with sevoflurane and remifentanil; muscle
relaxation was obtained with cisatracurium. During surgery, the pa-
tient’s hemodynamic conditions remained relatively stable, except for
an episode of severe hypotension (immediately after removal of the
tumor) that necessitated discontinuation of phentolamine infusion and
short-term administration of norepinephrine. Pathologic examination
of the mass confirmed the diagnosis of pheochromocytoma with be-
nign histologic appearance.
After excision of the tumor, the patient’s conditions rapidly im-
proved. Treatment with vasoactive drugs was stopped, and no residual
swings in blood pressure were observed. Renal function normalized,
and hemofiltration was discontinued. A progressive, continuous im-
provement in liver function was observed (bilirubin and indocyanine
green clearance at discharge were 3.7 mg/dl and 13.2%, respectively).
The patient was rapidly weaned from the ventilator and discharged
from our intensive care unit 29 days after admission with a residual
diffuse muscular weakness and severe functional impairment; an elec-
tromyographic study showed moderate distal axonal neuropathy asso-
ciated with signs of diffuse myopathy presumably related to the recent
rhabdomyolysis. The muscular weakness completely resolved a few
months after discharge from the hospital.
Discussion
We report here an acute catastrophic presentation of
an unrecognized case of pheochromocytoma in which
we applied extracorporeal cardiopulmonary assistance
for hemodynamic stabilization.
Pheochromocytomas are rare, catecholamine-produc-
ing tumors of chromaffin cells of the adrenal medulla
(85–90% of cases) or of a paraganglion. The prevalence
in hypertensive patients is 0.1–0.6%, but autopsy studies
reveal a relatively high prevalence (approximately
0.05%) of unrecognized tumors. Up to 25% of pheochro-
Table 1. Laboratory Values at Admission
Blood Test Value at Admission Normal Values
Leukocytes, 103/l 27,350 4–11
Hemoglobin, g/dl 15.5 12–18
Platelets, 103/l 406 140–440
Plasma sodium, mEq/l 145 135–145
Plasma potassium, mEq/l 4.55 3.4–4.8
Total calcium, mg/dl 7.1 8.5–10.3
Urea nitrogen, mg/dl 88 10–50
Plasma creatinine, mg/dl 2.6 0.5–1.5
Serum glucose, mg/dl 52 70–110
Total creatine kinase, U/l 4,201 20–180
CPK-MB, ng/ml 113 2.88
Plasma troponin T, ng/ml 13.8 0.01
Aspartate aminotransferase, U/l 1,584 8–41
Alanine aminotransferase, U/l 1,401 8–41
Serum amylase, U/l 574 0–100
Total bilirubin, mg/dl 0.6 0.1–1
CPK-MB  creatine kinase, MB fraction.
Fig. 1. Abdominal computed tomography scan showing a 7 
5-cm right adrenal mass with colliquated central region and
hypervascular peripheral rim.
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Fig. 2. On-line continuous monitoring of vital parameters over
a 2-h period, registered a few hours after bypass institution.
Frequent and rapid oscillations of systolic blood pressure (SBP;
top) are evident, with concomitant swings of heart rate (HR;
middle) and mixed venous blood saturation (SvO2; bottom).
Table 2. Plasmatic and Urinary Levels of Catecholamines and
of Their Metabolites
Blood Test Value Normal Range
Plasma epinephrine, pg/ml 10,319 10–67
Plasma norepinephrine, pg/ml 26,212 95–446
Urine metanephrine, g/24 h 3,431 52–341
Urine normetanephrine, g/24 h 2,820 88–444
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mocytomas may be familial. Hereditary pheochromocy-
tomas occur in multiple endocrine neoplasia type 2, von
Hippel-Lindau syndrome, neurofibromatosis type 1, and
the familial paragangliomas. Sporadic forms of pheo-
chromocytoma are usually diagnosed during the fifth
decade of life, whereas hereditary forms are diagnosed
earlier.1
Patients with pheochromocytoma typically have par-
oxysmal or sustained hypertension, associated with in-
termittent symptoms such as headache, sweating, and
palpitations. Other, less frequent symptoms include anx-
iety, tremors, nausea, fatigue, weight loss, and dyspnea.
Variability and lack of specificity of these clinical mani-
festations often hinder early diagnosis and treatment.
The diagnosis is based on the demonstration of cate-
cholamine excess by dosing urinary and plasma cat-
echolamines and metanephrines. The tumor is localized
by imaging studies (computed tomography, magnetic
resonance) of the adrenal glands and abdomen. Our
patient had no history of hypertension or other related
symptoms, and the presence of a pheochromocytoma
had never been suspected. In the past five decades, few
other cases of pheochromocytomas causing multiorgan
failure, cardiogenic shock, and rhabdomyolysis have
been reported.2–6
Rhabdomyolysis is attributed to diffuse skeletal muscle
ischemia due to catecholamine-mediated vasoconstric-
tion, but also to a focal myositis related to the direct
effect of catecholamines on the skeletal muscle fibers.2
Rhabdomyolysis is frequently complicated by myoglo-
binuric acute renal failure. In our patient, renal vasocon-
striction (revealed by the angiographic scan) may also
have contributed to the deterioration of renal function.
Similarly, the etiology of liver failure was presumably
multifactorial, with arterial vasoconstriction and passive
venous congestion contributing to its development and
progression. To monitor hepatic function, we used re-
peated assessments of indocyanine green clearance; this
is a reliable and sensitive test of global liver function but
cannot distinguish between failure due to splanchnic
hypoperfusion or to primary hepatocyte dysfunction.7
The cause of cardiogenic shock in patients with pheo-
chromocytoma is not completely understood, and sev-
eral mechanisms have been proposed.5,8 First, chronic
exposure to increased epinephrine levels probably
causes a down-regulation of  receptors on the myocar-
dium. Second, a direct toxic effect of catecholamines
leading to focal myocardial necrosis has been report-
ed.9,10 Third, hypocalcemia may play an important role:
Its effect may be particularly relevant when there are
rapid changes in serum calcium concentration or when
hypocalcemia combines with the synergistic effect of 
receptor down-regulation.11 Olson et al. hypothesized
that in epinephrine-secreting pheochromocytomas,
hypocalcemia may be due to increased calcium utili-
zation by the tumor or to an increase in bone calcium
deposition resulting from tumoral hypersecretion of
adrenomedullin.5,12
The distinctive feature of our case is certainly the use
of an extracorporeal cardiopulmonary assistance to sup-
port cardiac function. In 2000, Takagi et al.13 reported
the case of a 52-yr-old man with an occult pheochromo-
cytoma who developed refractory cardiogenic shock af-
ter administration of dexamethasone. Initial treatment
with an intraaortic balloon pump was ineffective, so a
“percutaneous cardiopulmonary support system” was
successfully instituted.
Likewise, our patient had refractory heart failure: Her
cardiac output was in the normal range (approximately 5
l/min) but inadequate for her metabolic needs, as dem-
onstrated by the low SvO2 and high blood lactate levels.
This apparently “normal” cardiac output was obtained
only at the cost of extremely high filling pressures,
which, in turn, had deleterious effects on liver perfusion.
Because optimal medical management did not restore
heart function, we decided to apply an invasive cardiac
support: We preferred a venoarterial bypass to intraaor-
tic balloon pump because our priority was to reduce
right heart preload rather then decreasing left heart
afterload.
Several drugs have been reported as triggers of cardio-
genic shock in patients with pheochromocytoma, such
as phenothiazine, phentolamine, and propranolol.14–16
In their article, Takagi et al.13 suggested that dexameth-
asone might have induced the shock. Steroids may trig-
ger acute heart failure, presumably by augmenting the
sensitivity of myocardial cells to catecholamines.17,18
Interestingly, our patient received therapy with methyl-
prednisolone during the first 2 days of intensive care unit
stay, but it is difficult to say whether this may have
contributed to the deterioration of cardiac function.
An intriguing observation is that in our patient the
marked blood pressure oscillations typical of pheochro-
mocytoma only occurred after the institution of the
extracorporeal assistance. Unstable blood pressure in
pheochromocytoma is due to episodic discharge of cat-
echolamines, and it is exaggerated by a reduced blood
volume.19 We can hypothesize that, before the bypass,
the maximal adrenergic activation (due to the refractory
heart failure and to therapeutic infusion) overrode the
vasopressor effects of the tumor. The hemodynamic im-
provement induced by the extracorporeal support led to
a reduction of the adrenergic tone and to withdrawal of
catecholamine infusion with normalization of sympa-
thetic reflexes. This, combined with the effect of blood
volume reduction allowed by the bypass and continuous
venovenous hemofiltration, might have unmasked the
vasoconstricting activity of tumoral catecholamines
pulses.
It is universally accepted that definitive treatment of
pheochromocytoma consists of its surgical excision. Be-
cause manipulation of the mass during surgery can lead
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to dramatic cardiovascular instability, angiographic tu-
mor embolization has been proposed in metastatic or
relapsing disease or in severely unstable patients.20,21 In
our patient, this approach did not obtain long-term con-
trol of pressure swings but was useful in avoiding major
hemodynamic instability during the surgical removal of
the tumor.
The authors thank the nursing and medical staff of the intensive care unit (San
Gerardo Hospital, Monza, Milan, Italy) for their dedication to patient care.
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